News
AstraZeneca beat second-quarter earnings expectations on Tuesday, helped by strong sales of key cancer, heart and kidney ...
Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.
AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer ...
Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...
STV Group, the Scottish media firm, has dropped as much as 33% after its profit warning. A tough advertising market is ...
The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...
InsideNoVa on MSN8d
AstraZeneca to build its largest-ever manufacturing facility in Virginia, creating hundreds of jobsIn a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...
AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...
British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...
The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback